Guanylthiourea (GTU) derivatives were identified as possible anti-malarial agents, recently, using in vitro studies on Plasmodium falciparum. This article gives an account of the in vivo anti-malarial activity of GTU derivatives against experimental rodent malaria. A total of 20 synthesized GTU derivatives were evaluated for in vivo antimalarial activity, out of which six showed encouraging results; one compound appeared to have curative potential. Molecular docking and molecular dynamics analysis were carried out to understand the molecular level interactions.
Keywords: Anti-malarials; Curative agent; Guanylthiourea; In vivo testing; Molecular docking; PfDHFR.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.